Dr. Muenzer is a pediatric geneticist and researcher, with special interest in congenital metabolic disorders such as Mucopolysaccharidoses (MPS). His research includes:
- Progressive brain disease in children with MPS II, also known as Hunter Syndrome.
- Developing new avenues of treatment in children with MPS, including clinical trials to test new forms of intravenous enzyme replacement therapy as well as alternative therapies, such as gene therapy and intrathecal drug delivery devices.
Links to more information:
- UNC Pediatrics Delivers Investigational Genome Editing Therapy in Clinical Trial for Hunter Syndrome
- UNC Healthcare News: Private Gift Supports UNC Research, Next Generation Leadership in MPS
|To learn more about how you can support the Children’s Research Institute, contact Keela Lyon, Senior Executive Director of Development, UNC Medicine, Children’s. Email or phone 919-843-2915.|